The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Precision Cancer Tests Market Research Report 2025
Synopsis
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
The global Precision Cancer Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Precision Cancer Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Precision Cancer Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Precision Cancer Tests in Cancer Research Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics and NanoString Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Tests.
Report Scope
The Precision Cancer Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Segment by Type
Imaging
In Vitro Diagnostic
Others
Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
The global Precision Cancer Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Precision Cancer Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Precision Cancer Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Precision Cancer Tests in Cancer Research Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics and NanoString Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Tests.
Report Scope
The Precision Cancer Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Segment by Type
Imaging
In Vitro Diagnostic
Others
Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging
1.2.3 In Vitro Diagnostic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Precision Cancer Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Tests Market Perspective (2019-2030)
2.2 Precision Cancer Tests Growth Trends by Region
2.2.1 Global Precision Cancer Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Precision Cancer Tests Historic Market Size by Region (2019-2024)
2.2.3 Precision Cancer Tests Forecasted Market Size by Region (2025-2030)
2.3 Precision Cancer Tests Market Dynamics
2.3.1 Precision Cancer Tests Industry Trends
2.3.2 Precision Cancer Tests Market Drivers
2.3.3 Precision Cancer Tests Market Challenges
2.3.4 Precision Cancer Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Tests Players by Revenue
3.1.1 Global Top Precision Cancer Tests Players by Revenue (2019-2024)
3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2019-2024)
3.2 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Tests Revenue
3.4 Global Precision Cancer Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2023
3.5 Precision Cancer Tests Key Players Head office and Area Served
3.6 Key Players Precision Cancer Tests Product Solution and Service
3.7 Date of Enter into Precision Cancer Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Tests Breakdown Data by Type
4.1 Global Precision Cancer Tests Historic Market Size by Type (2019-2024)
4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2025-2030)
5 Precision Cancer Tests Breakdown Data by Application
5.1 Global Precision Cancer Tests Historic Market Size by Application (2019-2024)
5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Precision Cancer Tests Market Size (2019-2030)
6.2 North America Precision Cancer Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Precision Cancer Tests Market Size by Country (2019-2024)
6.4 North America Precision Cancer Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Tests Market Size (2019-2030)
7.2 Europe Precision Cancer Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Precision Cancer Tests Market Size by Country (2019-2024)
7.4 Europe Precision Cancer Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Tests Market Size (2019-2030)
8.2 Asia-Pacific Precision Cancer Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Precision Cancer Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Precision Cancer Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Tests Market Size (2019-2030)
9.2 Latin America Precision Cancer Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Precision Cancer Tests Market Size by Country (2019-2024)
9.4 Latin America Precision Cancer Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Tests Market Size (2019-2030)
10.2 Middle East & Africa Precision Cancer Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Precision Cancer Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Precision Cancer Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Precision Cancer Tests Introduction
11.1.4 Abbott Revenue in Precision Cancer Tests Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Precision Cancer Tests Introduction
11.2.4 BD Revenue in Precision Cancer Tests Business (2019-2024)
11.2.5 BD Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Precision Cancer Tests Introduction
11.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Cynvenio Biosystems
11.4.1 Cynvenio Biosystems Company Detail
11.4.2 Cynvenio Biosystems Business Overview
11.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
11.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2019-2024)
11.4.5 Cynvenio Biosystems Recent Development
11.5 Foundation Medicine
11.5.1 Foundation Medicine Company Detail
11.5.2 Foundation Medicine Business Overview
11.5.3 Foundation Medicine Precision Cancer Tests Introduction
11.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2019-2024)
11.5.5 Foundation Medicine Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Detail
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Precision Cancer Tests Introduction
11.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2019-2024)
11.6.5 Genomic Health Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Precision Cancer Tests Introduction
11.7.4 Illumina Revenue in Precision Cancer Tests Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Detail
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Precision Cancer Tests Introduction
11.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2019-2024)
11.8.5 Myriad Genetics Recent Development
11.9 NanoString Technologies
11.9.1 NanoString Technologies Company Detail
11.9.2 NanoString Technologies Business Overview
11.9.3 NanoString Technologies Precision Cancer Tests Introduction
11.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2019-2024)
11.9.5 NanoString Technologies Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Precision Cancer Tests Introduction
11.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2019-2024)
11.10.5 QIAGEN Recent Development
11.11 Randox Laboratories
11.11.1 Randox Laboratories Company Detail
11.11.2 Randox Laboratories Business Overview
11.11.3 Randox Laboratories Precision Cancer Tests Introduction
11.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2019-2024)
11.11.5 Randox Laboratories Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche Precision Cancer Tests Introduction
11.12.4 Roche Revenue in Precision Cancer Tests Business (2019-2024)
11.12.5 Roche Recent Development
11.13 Philips
11.13.1 Philips Company Detail
11.13.2 Philips Business Overview
11.13.3 Philips Precision Cancer Tests Introduction
11.13.4 Philips Revenue in Precision Cancer Tests Business (2019-2024)
11.13.5 Philips Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Detail
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
11.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2019-2024)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imaging
Table 3. Key Players of In Vitro Diagnostic
Table 4. Key Players of Others
Table 5. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Precision Cancer Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Precision Cancer Tests Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Precision Cancer Tests Market Share by Region (2019-2024)
Table 9. Global Precision Cancer Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Precision Cancer Tests Market Share by Region (2025-2030)
Table 11. Precision Cancer Tests Market Trends
Table 12. Precision Cancer Tests Market Drivers
Table 13. Precision Cancer Tests Market Challenges
Table 14. Precision Cancer Tests Market Restraints
Table 15. Global Precision Cancer Tests Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Precision Cancer Tests Market Share by Players (2019-2024)
Table 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2023)
Table 18. Ranking of Global Top Precision Cancer Tests Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Precision Cancer Tests Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Precision Cancer Tests Product Solution and Service
Table 22. Date of Enter into Precision Cancer Tests Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Precision Cancer Tests Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Precision Cancer Tests Revenue Market Share by Type (2019-2024)
Table 26. Global Precision Cancer Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Precision Cancer Tests Revenue Market Share by Type (2025-2030)
Table 28. Global Precision Cancer Tests Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Precision Cancer Tests Revenue Market Share by Application (2019-2024)
Table 30. Global Precision Cancer Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Precision Cancer Tests Revenue Market Share by Application (2025-2030)
Table 32. North America Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Precision Cancer Tests Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Precision Cancer Tests Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Precision Cancer Tests Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Precision Cancer Tests Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Precision Cancer Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Precision Cancer Tests Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Precision Cancer Tests Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Precision Cancer Tests Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Precision Cancer Tests Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Precision Cancer Tests Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Precision Cancer Tests Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Precision Cancer Tests Product
Table 50. Abbott Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. BD Company Detail
Table 53. BD Business Overview
Table 54. BD Precision Cancer Tests Product
Table 55. BD Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 56. BD Recent Development
Table 57. Bio-Rad Company Detail
Table 58. Bio-Rad Business Overview
Table 59. Bio-Rad Precision Cancer Tests Product
Table 60. Bio-Rad Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 61. Bio-Rad Recent Development
Table 62. Cynvenio Biosystems Company Detail
Table 63. Cynvenio Biosystems Business Overview
Table 64. Cynvenio Biosystems Precision Cancer Tests Product
Table 65. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 66. Cynvenio Biosystems Recent Development
Table 67. Foundation Medicine Company Detail
Table 68. Foundation Medicine Business Overview
Table 69. Foundation Medicine Precision Cancer Tests Product
Table 70. Foundation Medicine Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 71. Foundation Medicine Recent Development
Table 72. Genomic Health Company Detail
Table 73. Genomic Health Business Overview
Table 74. Genomic Health Precision Cancer Tests Product
Table 75. Genomic Health Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 76. Genomic Health Recent Development
Table 77. Illumina Company Detail
Table 78. Illumina Business Overview
Table 79. Illumina Precision Cancer Tests Product
Table 80. Illumina Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 81. Illumina Recent Development
Table 82. Myriad Genetics Company Detail
Table 83. Myriad Genetics Business Overview
Table 84. Myriad Genetics Precision Cancer Tests Product
Table 85. Myriad Genetics Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 86. Myriad Genetics Recent Development
Table 87. NanoString Technologies Company Detail
Table 88. NanoString Technologies Business Overview
Table 89. NanoString Technologies Precision Cancer Tests Product
Table 90. NanoString Technologies Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 91. NanoString Technologies Recent Development
Table 92. QIAGEN Company Detail
Table 93. QIAGEN Business Overview
Table 94. QIAGEN Precision Cancer Tests Product
Table 95. QIAGEN Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 96. QIAGEN Recent Development
Table 97. Randox Laboratories Company Detail
Table 98. Randox Laboratories Business Overview
Table 99. Randox Laboratories Precision Cancer Tests Product
Table 100. Randox Laboratories Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 101. Randox Laboratories Recent Development
Table 102. Roche Company Detail
Table 103. Roche Business Overview
Table 104. Roche Precision Cancer Tests Product
Table 105. Roche Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Philips Company Detail
Table 108. Philips Business Overview
Table 109. Philips Precision Cancer Tests Product
Table 110. Philips Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 111. Philips Recent Development
Table 112. Thermo Fisher Scientific Company Detail
Table 113. Thermo Fisher Scientific Business Overview
Table 114. Thermo Fisher Scientific Precision Cancer Tests Product
Table 115. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2019-2024) & (US$ Million)
Table 116. Thermo Fisher Scientific Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Tests Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Precision Cancer Tests Market Share by Type: 2023 VS 2030
Figure 3. Imaging Features
Figure 4. In Vitro Diagnostic Features
Figure 5. Others Features
Figure 6. Global Precision Cancer Tests Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Precision Cancer Tests Market Share by Application: 2023 VS 2030
Figure 8. Cancer Research Centers Case Studies
Figure 9. Cancer Hospital Case Studies
Figure 10. Surgical Centers Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Precision Cancer Tests Report Years Considered
Figure 14. Global Precision Cancer Tests Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Precision Cancer Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Precision Cancer Tests Market Share by Region: 2023 VS 2030
Figure 17. Global Precision Cancer Tests Market Share by Players in 2023
Figure 18. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2023
Figure 20. North America Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Precision Cancer Tests Market Share by Country (2019-2030)
Figure 22. United States Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Precision Cancer Tests Market Share by Country (2019-2030)
Figure 26. Germany Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Precision Cancer Tests Market Share by Region (2019-2030)
Figure 34. China Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Precision Cancer Tests Market Share by Country (2019-2030)
Figure 42. Mexico Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Precision Cancer Tests Market Share by Country (2019-2030)
Figure 46. Turkey Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Precision Cancer Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 49. BD Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 50. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 51. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 52. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 53. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 54. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 55. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 56. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 57. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 58. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 59. Roche Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 60. Philips Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
